BiotechTube
Home/Thioredoxin Systems/Magnus Holmgren
MH

Magnus Holmgren

Board of Directors

Thioredoxin Systems

Therapeutic Areas

Infectious Disease

Thioredoxin Systems Pipeline

DrugIndicationPhase
EbsArgent™Complicated Urinary Tract Infections (cUTI) caused by antibiotic-resistant bacteriaPre-clinical

Leadership Team at Thioredoxin Systems

AS
Anna-Lena Sventelius
Board of Directors
View full Thioredoxin Systems profile